Covered recipient · General Payments record
LINDA E COLEMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$2,482.73
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $203.03 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $46.46 | 2 |
| Lilly USA, LLC | $42.98 | 2 |
| Galderma Laboratories, L.P. | $29.66 | 2 |
| Medtronic, Inc. | $24.55 | 1 |
| Exact Sciences Corporation | $23.09 | 1 |
| Novo Nordisk AS | $22.55 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.86 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018771411 | CMS |
| Abbott Laboratories | $23.60 | 05/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018782665 | CMS |
| Exact Sciences Corporation | $23.09 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026740769 | CMS |
| Galderma Laboratories, L.P. | $14.12 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059688313 | CMS |
| Galderma Laboratories, L.P. | $15.54 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059688315 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.74 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034432311 | CMS |
| Lilly USA, LLC | $17.66 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031880235 | CMS |
| Lilly USA, LLC | $25.32 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031776159 | CMS |
| Medtronic, Inc. | $24.55 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025683442 | CMS |
| Novo Nordisk Inc | $22.55 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001485571 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.